CD10 Flow Cytometry is a laboratory test that detects and measures CD10, a cell-surface marker expressed on certain immature and mature lymphoid and myeloid cells. Using flow cytometry, it helps identify and characterize specific cell populations in blood, bone marrow, or tissue samples. The test is needed to support the diagnosis and classification of certain leukemias, lymphomas, and other hematological disorders by evaluating cellular marker patterns.
No. CD10 is one marker within an immunophenotyping panel. Diagnosis requires correlation with other markers, blood or bone marrow findings, clinical history, and sometimes genetic or molecular tests.
CD10-positive means that the evaluated cells express CD10. The significance depends on the cell type, intensity of expression, and the results of other markers in the panel.
CD10-negative means significant CD10 expression was not detected in the evaluated cell population. This finding must be interpreted alongside the complete immunophenotyping profile.
Certainly. CD10 is normally expressed on certain immature B-cell precursors and some mature B-cell populations, as well as specific myeloid cells.
Yes. CD10 is frequently expressed in precursor B-cell acute lymphoblastic leukemia and can help support B-cell lineage and maturation-stage assessment alongside other markers.
Depending on the suspected condition, a panel may include CD19, CD20, CD22, CD23, CD5, CD34, CD45, CD79b, kappa, lambda, and other B- or T-cell markers.
OTP sent to your mobile number on whatsapp
Didn't recieved OTP Yet? Resend OTP
